9GPW: |
WHO Ninth General Programme of Work, 1996-2001 |
AAFB: |
Alcohol-acid-fast bacilli |
Ab: |
Antibody |
AFP: |
Acute flaccid paralysis |
AFRO: |
WHO Regional Office for the African Region |
Ag: |
Antigen |
AIDS: |
Acquired immunodeficiency syndrome |
aLRTI: |
Acute lower respiratory tract infections |
AMRO: |
see PAHO |
ARI: |
Acute respiratory tract infections |
BSE: |
Bovine spongiform encephalopathy |
CATT: |
Card agglutination trypanosomiasis test |
CD4: |
T4 lymphocyte population |
CDC: |
Centers for Disease Control and Prevention, Atlanta GA, USA |
CJD: |
Creutzfeldt-Jakob disease |
CMFL |
Community microfilarial load |
CSF: |
Cerebrospinal fluid |
DA: |
Direct agglutination test |
DEC: |
Diethylcarbamazine |
DFA: |
Direct fluorescent antibody |
DHF: |
Dengue haemorrhagic fever |
DPT: |
Diphtheria, pertussis, tetanus |
DSS: |
Dengue shock syndrome |
DT: |
Diphtheria, tetanus |
EEG: |
Electroencephalogram |
EIA: |
Enzyme immunoassay |
ELISA: |
Enzyme-linked immunosorbent assay |
EMRO: |
WHO Regional Office for the Eastern Mediterranean |
EPIET: |
European Programme for Intervention Epidemiology Training |
EURO: |
WHO Regional Office for the European Region |
FAT: |
Fluorescent antibody test |
FETP: |
Field Epidemiology Training Programme |
FFI: |
Fatal familial insomnia |
FluNet: |
Influenza network |
FTA: |
Fluorescent treponemal antibody-absorption |
GIS |
Geographic Information System |
GPS: |
Global Positioning System |
GSS: |
Gerstmann-Sträussler-Scheinker (syndrome) |
HAV: |
Hepatitis A virus |
HBcAg |
Hepatitis B core antigen |
HbeAg: |
Hepatitis B envelope antigen |
HbsAg: |
Hepatitis B surface antigen |
HBV: |
Hepatitis B virus |
HCV: |
Hepatitis C virus |
HDV: |
Hepatitis D virus |
HepB3: |
hepatitis B vaccine |
HEV: |
Hepatitis E virus |
HI |
Haemagglutination inhibition (test) |
Hib. |
Haemophilus influenzae type b |
HIV: |
Human immunodeficiency virus |
HTP: |
Hydroxytryptophane |
IARC: |
International Agency for Research in Cancer, WHO, Lyon, France |
ICD-10: |
International Classification of Diseases, 10th revision, WHO |
ID: |
Identification |
IF: |
Indirect Immunofluorescence |
IFA: |
Immunofluorescent assay |
IFAT: |
Indirect immunoflourescent antibody test |
IgG |
Immunoglobulin G |
IgM |
Immunoglobulin M |
IGO |
Intergovernmental organization |
IHR |
International Health Regulations |
IP |
Immunoperoxidase |
JE: |
Japanese encephalitis |
MAT: |
Microscopic Agglutination Test |
MDT: |
Multidrug therapy |
MNH: |
Programme on Mental Health, WHO |
MoH: |
Ministry of Health |
NGO: |
Nongovernmental organization |
NPEV: |
Non-poliomyelitis enterovirus |
nvCJD: |
New variant Creutzfeldt-Jakob disease |
OPV: |
Oral poliomyelitis vaccine |
PAB: |
Protected at Birth |
PAHO: |
Pan-American Health Organization |
PAS: |
Periodic acid-Schiff (stain) |
PCR: |
Polymerase chain reaction |
PrP: |
Protease-prion protein |
RPR: |
Rapid Plasma Reagin |
SEARO: |
WHO Regional Office for South-East Asia |
SRL: |
Supra-national reference laboratory |
STD: |
Sexually transmitted diseases |
Td: |
Tetanus-diphtheria [toxoid] |
TEPHINET: |
Training in Epidemiology and Public Health Intervention Network |
TPHA: |
Treponema pallidum haemagglutination antibodies |
TT: |
Tetanus toxoid |
UNAIDS: |
Joint United Nations Programme on HIV/AIDS |
VDRL: |
Venereal Disease Research Laboratory |
WHA: |
World Health Assembly |
WHO: |
World Health Organization |
WPRO: |
WHO Regional Office for the Western Pacific |